Table 3 Medical characteristics of the participants
From: Hepatitis C reinfection in former and active injecting drug users in Belgium
Characteristics | N (%) |
|---|---|
HIV coinfection | 0 |
Fibrosis | |
F0–F1 | 27 (43.5) |
F2 | 12 (19.4) |
F3 | 13 (21.0) |
F4 | 8 (12.9) |
Missing | 2 (3.2) |
Genotype | |
1a | 31 (51.7) |
1b | 7 (11.7) |
3 | 9 (15.0) |
4 | 5 (8.3) |
Missing | 8 (13.3) |
Year end of treatment | |
2015 | 1 (1.7) |
2016 | 6 (10.0) |
2017 | 7 (11.7) |
2018 | 9 (15.0) |
2019 | 30 (50.0) |
2020 | 7 (11.7) |